Algae Biotechnologies has developed the world's first integrated seaweed cultivation and biorefinery system capable of producing high-volume, low-cost biomethane and biohydrogen, while simultaneously recapturing CO₂ within the production process itself.

The Algae Biotechnologies biorefinery outputs can span: biomethane, biohydrogen, biostimulants, animal feeds, human foods, cosmeceuticals, pharmaceuticals and nutraceuticals. This is not just an incremental improvement, it is the offering of a categorically different approach to industrial bio-product production, with a negative emissions potential that no competing system can replicate.

The energy transition has a green gas problem.

The global transition away from coal and oil has created enormous and growing demand for natural gas as a bridging fuel. LNG demand is rising. Grid gas consumption remains at scale. Whether pipeline or liquefied, the environmental profile of fossil-derived natural gas is structurally incompatible with net-zero commitments. Based on volume, economics and rising security challenges, there is an urgent demand for self-sourced, high-output, low-cost green gas… and existing technologies are not scaleable or cost-competitive at the margins that matter.

The gap between ambition and available supply has not been closed. Until now.

The problem facing Green Gas:

What Is Required:

A green gas production system that is feedstock-dependent (and independent from constrained waste streams), cost-competitive with fossil gas at scale and capable of absorbing rather than emitting CO₂.

This is the specification that Algae Biotechnologies was built to meet.

Two systems. One closed loop. Zero atmospheric CO₂ release.

The Algae Biotechnologies platform integrates two proprietary systems:

  1. The Hygen Bioreactor (HBR), a high-rate mesophilic digestion system operating at 85–90% volatile solids destruction, invented and patented by Dr. N. Bartlett; and

  2. The terrestrial, in-tank continuous seaweed cultivation system developed and patented by Dr. D. Kalkwarf;

Together, they form a closed-loop production cycle:

  • Macroalgal seaweed grown as HBR feedstock absorbs marine carbon during photosynthetic growth;

  • the HBR degrades the organic material into base acids for downstream products or biomethane/biohydrogen for energy;

  • CO₂ generated during energy production is captured by microalgae photosynthesis and is either refined into downstream products or returned as nutrient input for the next seaweed growth cycle;

Zero waste. Zero emissions.

The Solution:

The HBR platform is not a single-product system. It is a configurable biorefinery, the output mix of biomethane, biohydrogen and high-value biological products determined by market conditions and offtake agreements, not by fixed technology constraints.

Every other biogas system releases CO₂. This one consumes it.

Biogas production of organic matter releases biogenic CO₂ as an unavoidable biochemical byproduct. Algae Biotechnologies eliminates this contradiction. The CO₂ produced within the HBR digestion process is captured and delivered directly to the micro-algae PBR, where it is consumed by photosynthesis as a biological growth input. The carbon does not leave the system boundary.

Fixing CO₂

No government with a net-negative emissions commitment, no investor with a beyond-zero mandate and no campaigner for meaningful climate action can find an equivalent system anywhere in the market.

This is the singular competitive position of Algae Biotechnologies.

Britain's gas network is one of the largest ready-market for green gas in the world. Algae Biotechnologies can build the system to supply it.

The United Kingdom consumes approximately 65 billion cubic metres of natural gas (heating, power generation and industrial processes) per year. Under the Climate Change Act and the UK's legally binding net-zero commitment for 2050, the entire fossil gas supply must be progressively replaced. Green gas grid injection is the only scalable pathway to decarbonise gas demand, without replacing the infrastructure that delivers it to 23 million homes and thousands of industrial sites. The volume required is enormous. The current supply of biomethane is a fraction of what is needed.

Algae Biotechnologies is building the production system to close this gap.

Market Option 1: The United Kingdom

The world's largest LNG producers face a common problem: their product's environmental profile is incompatible with the commitments of the nations buying it. Bio-LNG is the solution.

Qatar produces more than 100 million tonnes of LNG per year. It boasts the largest single LNG export programme in the world. The energy-importing nations that purchase this LNG: Europe, Asia and beyond are operating under progressively stringent carbon accounting requirements. The carbon intensity of imported LNG is increasingly a procurement criterion, not merely an environmental consideration. Gulf LNG producers that cannot demonstrate a credible decarbonisation pathway for their export product face long-term demand risk from their most significant customers.

Bio-LNG blending is the only near-term solution that does not require replacing existing production, shipping or import infrastructure.

Market Option 2: The Gulf

Market Option 3: The Rest of the World

Every coastal nation with a gas network, an LNG import terminal, or a net-zero commitment is a potential deployment market. The feedstock is the ocean.

The Algae Biotechnologies seaweed cultivation system is not geographically constrained. Marine macroalgae grow in every ocean on the planet. The conditions required for commercial cultivation: access to marine or brackish water, adequate light, CO₂ supply from the HBR system exist in coastal regions across Asia, Africa, Latin America and the Pacific. The HBR system itself is modular and scalable, deployable at any site with appropriate water access and grid or distribution infrastructure. The global addressable market is not a projection, it is a function of where coastlines and energy demand intersect, which is everywhere.

Horizon 1: UK & Europe

Biomethane grid injection across the UK and European gas networks.
EU REPowerEU targets require 35 billion cubic metres of biomethane production by 2030, a target that cannot be met from waste feedstocks alone. Seaweed-derived biomethane from HBR systems deployed in coastal European waters addresses this supply gap directly.

Horizon 2: Gulf & MENA

Bio-LNG production for blending with Gulf export programmes. Saudi Arabia, UAE, Oman and Qatar all have the incentive, the coastal geography and the infrastructure to integrate seaweed-to-Bio-LNG production into their existing LNG operations. The Gulf and Red Sea’s coastal waters present high seaweed productivity potential year-round.

Horizon 3: Asia & Pacific

India's SATAT framework provides a sovereign offtake mechanism for compressed biogas. Japan, South Korea and Singapore are all major LNG importers with advanced net-zero commitments and represent potential Bio-LNG import markets. Coastal nations with high fisheries and aquaculture infrastructure are natural seaweed cultivation partners.

Why Seaweed Scales

Seaweed is the high-volume answer for biomass supply: it is not geographically fixed, seasonally variable and already contested between competing uses: composting, direct land application thermal treatment. Seaweed can be cultivated at any scale in any coastal location, harvested continuously and grown specifically for fermentation without competing with food, agriculture or any other biological resource system. This is why seaweed is the feedstock for a genuinely global green gas industry at planetary scale.

The Scale of the Opportunity

Global Emissions, Carbon Sequestration & Hydrogen

Team

In conjunction with the Universities of Chester, Birmingham, Edinburgh and Lancaster, Algae Biotechnologies was built by scientists and environmentalists. The HBR system, the seaweed cultivation process, the photobioreactor and the hydrogen fermentation pathway were each created by members of this team, giving the organisation a depth of technical ownership that cannot be replicated through licensing or partnership alone.

The technology is ready. The markets are open. The window for deployment partnerships is now.

Algae Biotechnologies is actively seeking engagement from governments, energy system operators, sovereign investors and development finance institutions across the United Kingdom, the Gulf and global deployment markets. The HBR platform is at commercial development stage, past proof-of-concept and ready for scaled deployment with the right strategic and capital partners. Technical briefings, project co-development discussions and offtake framework negotiations are available to qualified parties.

Who Should Engage:

Engage with us

Request a Briefing

Qualified enquiries from government bodies, investment institutions and energy sector partners are invited to request a formal technical briefing. Briefings are available in person in the United Kingdom and via secure video conference for international counterparts. All engagement is conducted under mutual NDA.

Investment details, project financial structures, and deployment timelines are available under non-disclosure agreement to verified institutional and government counterparts only.

Contact: Jamie McIvor, Environmental Officer

Email: Jamie.mcivor@algaebiotech.co.uk